{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:56Z","timestamp":1782409796807,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F1-17.1\/2016-17\/RGNF-2015-17-SC-HAR-1109"],"award-info":[{"award-number":["F1-17.1\/2016-17\/RGNF-2015-17-SC-HAR-1109"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40199-019-00300-4","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T02:02:54Z","timestamp":1572919374000},"page":"661-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis"],"prefix":"10.1007","volume":"27","author":[{"given":"Gurpreet","family":"Kandav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak Kumar","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"300_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.apsb.2013.12.005","volume":"4","author":"P Zhou","year":"2014","unstructured":"Zhou P, Sun X, Zhang Z. Kidney targeted drug delivery system. Acta Pharm Sin B. 2014;4:37\u201342.","journal-title":"Acta Pharm Sin B"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000180438","volume":"14","author":"JR Klinenberg","year":"1975","unstructured":"Klinenberg JR, Kippen I, Bluestone R. Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition. Nephron. 1975;14:88\u201398.","journal-title":"Nephron."},{"key":"300_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jare.2017.04.005","volume":"8","author":"A Abou-Elela","year":"2017","unstructured":"Abou-Elela A. Epidemiology, pathophysiology, and management of uric acid urolithiasis: a narrative review. J Adv Res. 2017;8:513\u201327.","journal-title":"J Adv Res"},{"issue":"1","key":"300_CR4","first-page":"17","volume":"9","author":"TC Ngo","year":"2007","unstructured":"Ngo TC, Assimos DG. Uric acid nephrolithiasis: recent progress and future directions. Rev Urol. 2007;9(1):17.","journal-title":"Rev Urol"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/j.ackd.2013.06.003","volume":"20","author":"JE Zuckerman","year":"2013","unstructured":"Zuckerman JE, Davis ME. Targeting therapeutics to the glomerulus with nanoparticles. Adv Chronic Kidney Dis. 2013;20:500\u20137.","journal-title":"Adv Chronic Kidney Dis"},{"key":"300_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.4069","volume":"32","author":"H Nosrati","year":"2017","unstructured":"Nosrati H, Salehiabar M, Attari E, Davaran S, Danafar H, Manjili HK. Green and one-pot surface coating of iron oxide magnetic nanoparticles with natural amino acids and biocompatibility investigation. Appl Organometal Chem. 2017;32:e4069.","journal-title":"Appl Organometal Chem"},{"key":"300_CR7","doi-asserted-by":"publisher","first-page":"7423","DOI":"10.1007\/s11164-017-3084-3","volume":"43","author":"H Nosrati","year":"2017","unstructured":"Nosrati H, Salehiabar M, Davaran S, Ramazani A, Manjili HK, Danafar H. New advances strategies for surface functionalization of iron oxide magnetic nanoparticles (IONPs). Res Chem Intermed. 2017;43:7423\u201342.","journal-title":"Res Chem Intermed"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.biomaterials.2007.08.050","volume":"29","author":"B Chertok","year":"2008","unstructured":"Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29:487\u201396.","journal-title":"Biomaterials."},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nano.2009.04.002","volume":"6","author":"A Kumar","year":"2010","unstructured":"Kumar A, Jena PK, Behera S, Lockey RF, Mohapatra S, Mohapatra S. Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine. 2010;6:64\u20139.","journal-title":"Nanomedicine."},{"key":"300_CR10","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.5012\/bkcs.2012.33.10.3225","volume":"33","author":"S Alimohammadi","year":"2012","unstructured":"Alimohammadi S, Salehi R, Amini N, Davaran S. Synthesis and physicochemical characterization of biodegradable PLGA-based magnetic nanoparticles containing amoxicilin. Bull Kor Chem Soc. 2012;33:3225\u201332.","journal-title":"Bull Kor Chem Soc"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.apt.2010.01.008","volume":"21","author":"J Qu","year":"2010","unstructured":"Qu J, Liu G, Wang Y, Hong R. Preparation of Fe3O4\u2013chitosan nanoparticles used for hyperthermia. Adv Powder Technol. 2010;21:461\u20137.","journal-title":"Adv Powder Technol"},{"key":"300_CR12","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.2147\/IJN.S35746","volume":"7","author":"D Dorniani","year":"2012","unstructured":"Dorniani D, Hussein MZ, Kura AU, Fakurazi S, Shaari AH, Ahmad Z. Preparation of Fe3O4 magnetic nanoparticles coated withgallic acid for drug delivery. Int J Nanomedicine. 2012;7:5745.","journal-title":"Int J Nanomedicine"},{"key":"300_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","volume":"4","author":"P Bhagav","year":"2011","unstructured":"Bhagav P, Upadhyay H, Chandran S. Brimonidine tartrate\u2013Eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation. AAPS PharmSciTech. 2011;4:1087\u2013101.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"300_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1080\/10717544.2017.1377315","volume":"24","author":"M Yadav","year":"2017","unstructured":"Yadav M, Parle M, Sharma N, Dhingra S, Raina N, Jindal DK. Brain targeted oral delivery of doxycycline hydrochloride encapsulated tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice. Drug Delivery. 2017;24(1):1429\u201340.","journal-title":"Drug Delivery"},{"key":"300_CR15","doi-asserted-by":"publisher","first-page":"e0151344","DOI":"10.1371\/journal.pone.0151344","volume":"11","author":"HK Manjili","year":"2016","unstructured":"Manjili HK, Ma\u2019mani L, Tavaddod S, Mashhadikhan M, Shafiee A, Naderi-Manesh H. D, L-sulforaphane loaded Fe3O4@ gold core shell nanoparticles: a potential sulforaphane delivery system. PLoS One. 2016;11:e0151344.","journal-title":"PLoS One"},{"key":"300_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.ijbiomac.2016.12.065","volume":"96","author":"P Girotra","year":"2017","unstructured":"Girotra P, Thakur A, Kumar A, Singh SK. Identification of multi-targeted anti-migraine potential of nystatin and development of its brain targeted chitosan nanoformulation. Int J Biol Macromol. 2017;96:687\u201396.","journal-title":"Int J Biol Macromol"},{"key":"300_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0043-120197","volume":"68","author":"M Salehiabar","year":"2018","unstructured":"Salehiabar M, Nosrati H, Davaran S, Danafar H, Manjili HK. Facile synthesis and characterization of l-aspartic acid coated iron oxide magnetic nanoparticles (IONPs) for biomedical applications. Drug Res. 2018;68:280\u20135.","journal-title":"Drug Res"},{"key":"300_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.22159\/ijap.2019v11i3.31932","volume":"11","author":"G Kandav","year":"2019","unstructured":"Kandav G, Bhatt DC, Jindal DK. Formulation and evaluation of allopurinol loaded chitosan nanoparticles. Int J Appl Pharm. 2019;11:49\u201352.","journal-title":"Int J Appl Pharm"},{"key":"300_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/03639045.2017.1417422","volume":"44","author":"H Nosrati","year":"2018","unstructured":"Nosrati H, Salehiabar M, Davaran S, Danafar H, Manjili HK. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Drug Dev Ind Pharm. 2018;44:886\u201394.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1-2","key":"300_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0378-5173(96)04550-4","volume":"139","author":"Z Zhang","year":"1996","unstructured":"Zhang Z, Liao G, Nagai T, Hou S. Mitoxantrone polybutyl cyanoacrylate nanoparticles as an anti-neoplastic targeting drug delivery system. Int J Pharm. 1996;139(1-2):1\u20138.","journal-title":"Int J Pharm"},{"key":"300_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fitote.2015.06.002","volume":"105","author":"PY Hou","year":"2015","unstructured":"Hou PY, Mi C, He Y, Zhang J, Wang SQ, Yu F, et al. Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice. Fitoterapia. 2015;105:43\u20138.","journal-title":"Fitoterapia."},{"key":"300_CR22","doi-asserted-by":"crossref","first-page":"40305","DOI":"10.18632\/oncotarget.16928","volume":"8","author":"X Meng","year":"2017","unstructured":"Meng X, Mao Z, Li X, Zhong D, Li M, Jia Y, et al. Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice. Oncotarget. 2017;8:40305.","journal-title":"Oncotarget."},{"key":"300_CR23","first-page":"424","volume":"20","author":"A Halabe","year":"1994","unstructured":"Halabe A, Sperling O. Uric acid nephrolithiasis. Miner Electrolyte Metab. 1994;20:424\u201331.","journal-title":"Miner Electrolyte Metab"},{"key":"300_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7897\/2277-4343.085243","volume":"8","author":"Sangameshwar","year":"2017","unstructured":"Sangameshwar, Chandramouli HM, Medikeri SS, Hiremath SG. Evaluation of antihyperuricemic activity of shodhita shilajatu on potassium oxonate induced hyperuricemic rat model. Int J Res Ayurveda Pharm. 2017;8:53\u20138.","journal-title":"Int J Res Ayurveda Pharm"},{"key":"300_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00604-008-0044-z","volume":"164","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Yang X, Lu W, Liao H, Liao F. Uricase based methods for determination of uric acid in serum. Microchim Acta. 2009;164:1\u20136.","journal-title":"Microchim Acta"},{"key":"300_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2710.2003.00488.x","volume":"28","author":"H Tada","year":"2003","unstructured":"Tada H, Fujisaki A, Itoh K, Suzuki T. Facile and rapid high-performance liquid chromatography method for simultaneous determination of allopurinol and oxypurinol in human serum. J Clin Pharm Ther. 2003;28:229\u201334.","journal-title":"J Clin Pharm Ther"},{"key":"300_CR27","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1080\/10826079308019705","volume":"16","author":"JM Degroodt","year":"1993","unstructured":"Degroodt JM, Bukanski BW, Srebrnik S. Multiresidue analysis of tetracyclines in kidney by HPLC and photodiode array detection. J Liq Chromatogr Relat Technol. 1993;16:3515\u201329.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"300_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1248\/cpb.c12-00732","volume":"61","author":"K Nagpal","year":"2013","unstructured":"Nagpal K, Singh SK, Mishra DN. Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake. Chem Pharm Bull. 2013;61:258\u201372.","journal-title":"Chem Pharm Bull"},{"key":"300_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jpba.2007.08.002","volume":"45","author":"MK Reinders","year":"2007","unstructured":"Reinders MK, Nijdam LC, van Roon EN, Movig KL, Tim LT, van de Laar MA, et al. A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection. J Pharm Biomed Anal. 2007;45:312\u20137.","journal-title":"J Pharm Biomed Anal"},{"key":"300_CR30","first-page":"781","volume":"80","author":"G Kandav","year":"2018","unstructured":"Kandav G, Singh SK. Review of Nanoemulsion formulation and characterization techniques. Indian J Pharm Sci. 2018;80:781\u20139.","journal-title":"Indian J Pharm Sci"},{"key":"300_CR31","first-page":"241","volume":"7","author":"K Tayal","year":"2015","unstructured":"Tayal K, Kandav G, Girotra P, Singh SK. Formulation and evaluation of chitosan coated magnetic nanoparticles of amoxicillin trihydrate. Pharm Lett. 2015;7:241\u201325.","journal-title":"Pharm Lett"},{"key":"300_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","volume":"47","author":"M Fazil","year":"2012","unstructured":"Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47:6\u201315.","journal-title":"Eur J Pharm Sci"},{"key":"300_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37\u201342.","journal-title":"J Control Release"},{"key":"300_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.onano.2017.04.002","volume":"2","author":"C Chavan","year":"2017","unstructured":"Chavan C, Bala P, Pal K, Kale SN. Cross-linked chitosan-dextran sulphate vehicle system for controlled release of ciprofloxacin drug: an ophthalmic application. OpenNano. 2017;2:28\u201336.","journal-title":"OpenNano."},{"key":"300_CR35","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1166\/jnn.2015.9544","volume":"15","author":"S Vikram","year":"2015","unstructured":"Vikram S, Dhakshnamoorthy M, Vasanthakumari R, Rajamani AR, Rangarajan M, Tsuzuki T. Tuning the magnetic properties of iron oxide nanoparticles by a room-temperature air-atmosphere (RTAA) co-precipitation method. J Nanosci Nanotechnol. 2015;15:3870\u20138.","journal-title":"J Nanosci Nanotechnol"},{"key":"300_CR36","volume":"7","author":"XN Pham","year":"2016","unstructured":"Pham XN, Nguyen TP, Pham TN, Tran TT, Tran TV. Synthesis and characterization of chitosan-coated magnetite nanoparticles and their application in curcumin drug delivery. Adv Nat Sci: Nanosci Nanotechnol. 2016;7:045010.","journal-title":"Adv Nat Sci: Nanosci Nanotechnol"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40199-019-00300-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-019-00300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:23:15Z","timestamp":1604449395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40199-019-00300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s40199-019-00300-4","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"23 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}